Search results
Results From The WOW.Com Content Network
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinical outcome measure for stroke clinical trials. [1] [2]
The National Institutes of Health Stroke Scale has been repeatedly validated as a tool for assessing stroke severity and as an excellent predictor for patient outcomes. [ 21 ] [ 22 ] [ 23 ] Severity of a stroke is heavily correlated with the volume of brain affected by the stroke; strokes affecting larger portions of the brain tend to have more ...
It found that the conditioning reduced the incidence of recurrent stroke from 23.3% to 5% at 90 days, and from 26.7% to 7.9% at 300 days; it also improved the rate of recovery (measured with the modified Rankin scale) and cerebral perfusion. The second trial examined the effect of 180 days of RIC on symptomatic ICAS in Chinese people aged 80 ...
A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.
DECATUR, Ga. - Carol Rankin counts herself among the fortunate survivors of a hemorrhagic stroke, a rare and deadly form of stroke. Rankin, 65, suffered the stroke while taking a horse-riding ...
The Glasgow Outcome Scale is widely used in clinical settings to evaluate patients who have suffered brain injury. It is the recommended outcomes measure for major trauma and head injury by many national-level organizations, including the NIH National Institute of Child Health and Human Development, and the National Institute of Neurological ...
Fugl-Meyer Assessment (FMA) scale is an index to assess the sensorimotor impairment in individuals who have had stroke. [1] This scale was first proposed by Axel Fugl-Meyer and his colleagues as a standardized assessment test for post-stroke recovery in their paper titled The post-stroke hemiplegic patient: A method for evaluation of physical performance.
The scale is regarded as reliable, although its use in clinical trials in stroke medicine is inconsistent. [4] It has however, been used extensively to monitor functional changes in individuals receiving in-patient rehabilitation, mainly in predicting the functional outcomes related to stroke.